After the adjustment, HOMA-IR, the hepatic enzymes ALT, AST, and GGT, insulin, and triglycerides exhibited statistically significant differences between the control and NASH patients. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatohepatitis.